XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018

FDA approved Anti-Cancer medicine XOSPATA (gilteritinib) tablets is available upon request. Get best retail price of XOSPATA (gilteritinib) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@medvitaz.com. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical Oncologist.
Categories: , .

XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018

INDICATIONS AND USAGE
XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
DOSAGE FORMS & STRENGTHS
120 mg orally once daily.
Manufactured By: Astellas Pharma US, Inc
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR XOSPATA (gilteritinib) tablets?

FDA approved Anti-Cancer medicine XOSPATA (gilteritinib) tablets is available upon request. Get best retail price of XOSPATA (gilteritinib) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@medvitaz.com. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical Oncologist.

Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of AXL receptor tyrosine kinase, hence it is a tyrosine kinase inhibitor. It was developed by Astellas Pharma.
In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia (AML).
In November 2018, the FDA approved gilteritinib for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
Gilteritinib was granted orphan drug status by the U.S. FDA, the European Commission (EC) and the Japan Ministry of Health, Labor and Welfare, for some AML patients.
Gilteritinib was approved for medical use in Australia in March 2020.

HOW AND WHERE TO BUY gilteritinib tablets?

You can order gilteritinib tablets direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of gilteritinib tablets in India, Call 8750295029 or Email urgent@medvitaz.comFDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.